SEC Form 4 · accession 0001140361-15-014807
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Reiser
Officer — President - ResMed Europe
Period of report
Apr 6, 2015
Accepted (ET)
Apr 8, 2015 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Apr 6, 2015 | M | 3,000 | $17.30 | A | 71,120 | D | |
| ResMed Common Stock | Apr 6, 2015 | S | 3,000 | $73.95 | D | 68,120 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed NQ Stock Options | $17.30 | Apr 6, 2015 | M | 3,000 | D | Nov 24, 2012 | Nov 24, 2015 | ResMed Common Stock | 3,000 | 12,000 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.